VENENUM Biodesign is part of the Genesis Biotechnology Group (GBG), an integrated life science company, located conveniently in Hamilton, New Jersey, and is easily accessible to other academic centers, medical centers, biotech, and pharmaceutical companies in the New York/ New Jersey/ Pennsylvania area. GBG is owned by Dr. Eli Mordechai. GBG consists of a family of research and development companies and institutes that focus on discovering and advancing innovative new medicines and biomarkers for significant unmet medical needs. Our therapeutic areas include cancer, inflammation, infectious diseases, metabolic diseases, and women’s health. Our business model allows us to focus on the creation of high value, innovative diagnostic tests and biomarkers, and small molecule drug programs at targets identified from our own research and to work with partners for clinical and commercial development to bring our products to patients.